N4P.L

N4 Pharma Plc [N4P.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

N4P.L Stock Summary

Top 10 Correlated ETFs

N4P.L

Top 10 Correlated Stocks

N4P.L

In the News

N4P.L Financial details

Company Rating
-
Market Cap
1.83M
Income
-2.25M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
5
Optionable
No
Shortable
Yes
Earnings
07 Mar 2024
P/E
-2.05
Forward P/E
-
PEG
-0.62
P/S
-
P/B
1.01
P/C
-
P/FCF
-3.67
Quick Ratio
24.64
Current Ratio
27.81
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-35.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
133.33%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-48%
ROE
-49%
ROC
-0.57%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.6-2.3
52W High
-
52W Low
-
RSI
56
Rel Volume
0.38
Avg Volume
757.58K
Volume
291.01K
Perf Week
-4.55%
Perf Month
10.53%
Perf Quarter
0%
Perf Half Y
0%
-
-
-
-
Beta
-0.026
-
-
Volatility
0.03%, 0.03%
Prev Close
0%
Price
0.525
Change
0%

Something similar

Top by Market Cap
ABEA.DE
BRK-A
LLY.DE
VTSAX
1YD.DE
Top Correlated ETFs
ISXF.L
5MVL.DE
INXG.L
IAEX.L
OPEN.DE
Top Correlated Stocks
HMT.NS
CRCL.L
FACC.VI
TKO.PA
0HTF.L
Similar Market Cap
LBUY
SWEB
MOBQ
ZAIM.L
PHIO

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 757.58K
  • Market Capitalization 1.83M
  • Employee 5
  • CEO Mr. Nigel James Theobald
  • Headquarters London,GB
  • IPO Date 1988-07-01
  • Website https://www.n4pharma.com

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.